Simplex Trading, LLC Vascular Biogenics Ltd. Transaction History

Simplex Trading, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$0.13 - $0.19 $13,535 - $19,782	-104,119 Reduced 99.9%	100 $0
Q4 2022 Feb 02, 2023	SELL	$0.11 - $0.16 $668 - $972	-6,079 Reduced 5.51%	104,219 $12,000
Q3 2022 Nov 04, 2022	BUY	$0.15 - $2.1 $3,148 - $44,081	20,991 Added 23.5%	110,298 $17,000
Q2 2022 Aug 03, 2022	BUY	$1.22 - $1.95 $108,954 - $174,148	89,307 New	89,307 $143,000
Q4 2019 Feb 05, 2020	SELL	$1.1 - $1.32 $244 - $293	-222 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$1.11 - $1.42 $345 - $441	-311 Reduced 58.35%	222 $0
Q2 2019 Jul 26, 2019	BUY	$1.16 - $1.53 $12 - $16	11 Added 2.11%	533 $0
Q1 2019 Apr 18, 2019	BUY	$0.94 - $1.75 $490 - $913	522 New	522 $0
Q4 2018 Jan 16, 2019	SELL	$0.6 - $1.72 $346 - $992	-577 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$1.55 - $2.17 $4,650 - $6,510	-3,000 Reduced 83.87%	577 $0
Q2 2018 Jul 30, 2018	BUY	$2.05 - $3.0 $7,332 - $10,731	3,577 New	3,577 $7,000
Q4 2017 Jan 10, 2018	SELL	$5.65 - $9.0 $4,011 - $6,390	-710 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$4.15 - $7.2 $2,946 - $5,112	710	710 $4,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.